FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and may be used to heal wound epithelium of various genesis. For this purpose an agent is introduced into wound, causing modulation of expression and/or activity of one isoform PKC and therapeutically effective amount of one additional facility selected from group that consists of insulin, growth factor, adipokin, PKC RACK and GW9662. According pharmaceutical compositions are proposed for introduction in wound, containing, apart from therapeutically effective amounts of necessary substances, a pharmaceutically acceptable carrier.
EFFECT: accelerated processes of epithelium wound healing by explicit synergetic action of specified substances.
60 cl, 43 dwg, 10 tbl, 27 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS AND PHARMACOLOGICAL COMPOSITIONS FOR WOUND HEALING | 2004 |
|
RU2392959C1 |
METHODS AND PHARMACOLOGICAL COMPOSITIONS FOR WOUND HEALING | 2004 |
|
RU2491952C2 |
WAYS AND PHARMACOLOGICAL COMPOSITIONS FOR HEALING OF WOUNDS | 2004 |
|
RU2359694C2 |
PHARMACEUTICAL COMPOSITIONS AND WOUND HEALING ACCELERATION TECHNIQUES | 2004 |
|
RU2358753C2 |
APPLICATION OF ADIPOCYTES, PRE-ADIPOCYTES AND STEM CELLS FOR INDUCTION OR ACCELERATION OF WOUND HEALING AND PHARMACEUTICAL COMPOSITION, CONTAINING THEM | 2009 |
|
RU2419441C2 |
INDOLYLMALEIMIDE DERIVATIVES | 2005 |
|
RU2373201C2 |
PHARMACEUTICAL COMPOSITION AND RELATED METHODS | 2008 |
|
RU2502520C2 |
METHODS OF REGULATING INFLAMMATION MEDIATORS AND PEPTIDES USED IN THEM | 2007 |
|
RU2429004C2 |
METHOD OF IDENTIFICATION OF INHIBITORS OR AGONISTS OF PROTEIN KINASE IRS | 2004 |
|
RU2340898C2 |
WOUND HEALING TECHNIQUE WITH INTRODUCING HUMAN IL-18 | 2005 |
|
RU2387455C2 |
Authors
Dates
2010-11-27—Published
2008-09-29—Filed